Famed short-seller Jim Chanos shares his views on investing and betting against companies in an exclusive interview for CNBC PRO with Mike Santoli. On the healthcare and medical services industry: “We believe pretty strongly that a sea change is happening in the U.S. health-care system. That we are embarked upon the ending of health-care […]
Read moreThe Wells Fargo Investment Institute doesn’t expect the S&P 500 to rise more than 2 percent over the next 15 months, according to the firm’s 2018 year-end outlook released Thursday. While some Wall Street strategists have included 2018 S&P targets in their equities notes, the Wells Fargo note marks the first major outlook report for […]
Read moreClosely followed trader Art Cashin warned on Thursday that the current Federal Reserve leadership will likely not be around next year and he doesn’t think the central bank will implement three interest rate hikes in 2018. On Wednesday, the Fed announced it will begin to roll off its $4.5 trillion balance sheet next month, but […]
Read moreThe finance professor who correctly called the Dow Jones industrial average’s surge to 20,000 said he expects stocks to jump even higher in the last 101 days of the year. The Wharton School’s Jeremy Siegel believes it’ll have a lot to do with President Donald Trump’s intention to get business-friendly reforms passed on Capitol Hill […]
Read moreGuggenheim Partners chief investment officer Scott Minerd downplayed reports that there was upheaval at the firm, telling CNBC on Monday “there is no tumult.” Reports have included that Mark Walter was considering stepping down as CEO and that there was a power struggle between Walter and Minerd. Minerd called the characterization of a power struggle […]
Read moreWarren Buffett may be famous for his investing skill, but his lounge act isn’t bad, either. He took to the stage as recently as Tuesday night, at the centennial party for Forbes magazine in New York, where he teamed up with Stevie Wonder to sing Billy Hill’s 1936 classic “The Glory of Love.” Buffett likes […]
Read more
The giants of the internet economy are typically cast as the leading fetish objects for growth investors. But compared to the TAMP stocks, FANG looks a bit dull. What’s TAMP, you ask? That would be Thermo Fisher Scientific, Agilent, Mettler-Toledo and PerkinElmer, just a few of the seldom-discussed names that have powered the obscure S&P […]
Read moreIt has been a good year for Johnson & Johnson shareholders, but now Goldman Sachs says investors should ring the register. The firm on Wednesday lowered its rating for the company to sell from neutral, predicting the drugmaker’s earnings growth will lag its peers during the next five years. After the note, the stock was […]
Read moreThere has been a great deal of discussion concerning tax reform these days, and many people are putting tax planning on hold until they see what Congress is actually going to do. Since that could take a lot of time and we don’t know if any changes will actually occur, it makes more sense to […]
Read moreL Brands shares have plummeted this year due to sales declines and poor financial guidance. The disappointing results are likely to continue, according to one Wall Street firm. After being wrong with its bullish call for L Brands all year, Cowen gave up Wednesday and lowered its rating to market perform from outperform. The firm […]
Read more